bupivacaine + meloxicam + ibuprofen + acetaminophen

This is a four-drug combination of the local anesthetic **bupivacaine**, the non-steroidal anti-inflammatory drugs (NSAIDs) **meloxicam** and **ibuprofen**, and the non-opioid analgesic **acetaminophen**. Each component has a distinct mechanism of action for pain relief. Bupivacaine blocks nerve impulse conduction, providing local anesthesia. Meloxicam and ibuprofen inhibit prostaglandin synthesis via cyclooxygenase (COX) enzyme inhibition, offering anti-inflammatory and analgesic effects. Acetaminophen provides central analgesia, likely by inhibiting prostaglandin synthesis in the central nervous system. While dual and triple combinations of these ingredients (such as bupivacaine + meloxicam [found in Zynrelef], or combinations of acetaminophen + ibuprofen) are approved and commonly used for multimodal pain management, there is no known approved or branded form of all four ingredients combined in a single pharmaceutical product. Clinical studies often use multimodal analgesia regimens including all four, but these are administered as separate products or combinations and not as a fixed-dose combination.